GLANZMANN THROMBASTHENIA
Clinical trials for GLANZMANN THROMBASTHENIA explained in plain language.
Never miss a new study
Get alerted when new GLANZMANN THROMBASTHENIA trials appear
Sign up with your email to follow new studies for GLANZMANN THROMBASTHENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug may offer longer-lasting bleed control for rare platelet disorder
Disease control CompletedThis lab study tested whether concizumab, a drug that blocks a natural clotting inhibitor, can improve blood clotting in people with Glanzmann thrombasthenia (GT), a rare genetic bleeding disorder. Blood samples from 20 adults with GT and healthy donors were mixed with concizumab…
Matched conditions: GLANZMANN THROMBASTHENIA
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New blood test could unmask hidden bleeding disorders
Diagnosis CompletedThis study tested a new lab method to diagnose platelet function disorders in 322 people with bleeding symptoms. The method uses flow cytometry to detect signaling defects in platelets, which are often missed by standard tests. The goal was to standardize the technique across mul…
Matched conditions: GLANZMANN THROMBASTHENIA
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC
-
Rare bleeding disorder study seeks to unlock antibody mystery
Knowledge-focused CompletedThis study looked at 28 people with Glanzmann thrombasthenia, a rare bleeding disorder, to understand why some develop harmful antibodies after blood transfusions or pregnancy. Researchers checked for antibodies every six months and after each transfusion over 18 months. The goal…
Matched conditions: GLANZMANN THROMBASTHENIA
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC